IDEAS home Printed from https://ideas.repec.org/a/rom/rmcimn/v12y2011i6p160-165.html
   My bibliography  Save this article

Knowledge Management, the Competitive Advantage for Pharmaceutical Companies

Author

Listed:
  • Alexandra CALDARARU

    (The Bucharest Academy of Economic Studies, Romania)

Abstract

The latest achievements in knowledge-based economy are supporting the existence of important features: the primacy of knowledge in all spheres of economic activity ; intellectual property has a considerable weight in national heritage, to base economic activities is done primarily on intangible resources (knowledge represented by competent people) and only then on tangible resources, economic activities focusing on knowledge accumulation and production of goods - knowledge, the production demasification, the majority share of the permanent growing service sector, the knowledge basis for competitive advantage predominantly owned and used. The main role of business in such an economy is that to obtain, protect, integrate and exploit the specialized knowledge, which gives it a competitive power market. In this case management is not just about a simple knowledge processing but task is to integrate them into the organization. Information technology, human capital, capabilities and competencies of the organization begin to play a increasingly important role within firms.

Suggested Citation

  • Alexandra CALDARARU, 2011. "Knowledge Management, the Competitive Advantage for Pharmaceutical Companies," REVISTA DE MANAGEMENT COMPARAT INTERNATIONAL/REVIEW OF INTERNATIONAL COMPARATIVE MANAGEMENT, Faculty of Management, Academy of Economic Studies, Bucharest, Romania, vol. 12(6), pages 160-165, December.
  • Handle: RePEc:rom:rmcimn:v:12:y:2011:i:6:p:160-165
    as

    Download full text from publisher

    File URL: https://rmci.ase.ro/no12vol1s/Vol-12_No-1S_Article-26.pdf
    Download Restriction: no
    ---><---

    More about this item

    Keywords

    knowledge management; knowledge; knowledge organization; intellectual capital; pharmaceutical company.;
    All these keywords.

    JEL classification:

    • M10 - Business Administration and Business Economics; Marketing; Accounting; Personnel Economics - - Business Administration - - - General
    • M19 - Business Administration and Business Economics; Marketing; Accounting; Personnel Economics - - Business Administration - - - Other

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:rom:rmcimn:v:12:y:2011:i:6:p:160-165. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Marian Nastase (email available below). General contact details of provider: https://edirc.repec.org/data/mnasero.html .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.